Anika Therapeutics, Inc. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit: ratio: %
Description: Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary: Anika Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
Anika Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -48.1 %, a 442% decline year-over-year.
Anika Therapeutics, Inc. annual Return On Equity for 2023 was -32 %, a 515% decline from 2022.
Anika Therapeutics, Inc. annual Return On Equity for 2022 was -5.2 %, a 459% decline from 2021.
Anika Therapeutics, Inc. annual Return On Equity for 2021 was 1.45 %.

Return On Equity, Quarterly (%)

Return On Equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date
Q3 2024	-48.1	-39.2	-442%	Jul 1, 2024	Sep 30, 2024
Q2 2024	-32.9	-25	-316%	Apr 1, 2024	Jun 30, 2024
Q1 2024	-31.8	-24	-305%	Jan 1, 2024	Mar 31, 2024
Q4 2023	-32	-26.8	-515%	Oct 1, 2023	Dec 31, 2023
Q3 2023	-8.87	-3.37	-61.2%	Jul 1, 2023	Sep 30, 2023
Q2 2023	-7.9	-4.07	-106%	Apr 1, 2023	Jun 30, 2023
Q1 2023	-7.86	-7.29	-1280%	Jan 1, 2023	Mar 31, 2023
Q4 2022	-5.2	-6.65	-459%	Oct 1, 2022	Dec 31, 2022
Q3 2022	-5.51	-3.47	-170%	Jul 1, 2022	Sep 30, 2022
Q2 2022	-3.83	+0.7	+15.4%	Apr 1, 2022	Jun 30, 2022
Q1 2022	-0.57	+9.03	+94%	Jan 1, 2022	Mar 31, 2022
Q4 2021	1.45	+9.87		Oct 1, 2021	Dec 31, 2021
Q3 2021	-2.04	-0.56	-37.8%	Jul 1, 2021	Sep 30, 2021
Q2 2021	-4.53	-8.47	-215%	Apr 1, 2021	Jun 30, 2021
Q1 2021	-9.6	-19.8	-194%	Jan 1, 2021	Mar 31, 2021
Q4 2020	-8.42	-18.4	-184%	Oct 1, 2020	Dec 31, 2020
Q3 2020	-1.48	-13.1	-113%	Jul 1, 2020	Sep 30, 2020
Q2 2020	3.94	-7.33	-65.1%	Apr 1, 2020	Jun 30, 2020
Q1 2020	10.2	-1.35	-11.7%	Jan 1, 2020	Mar 31, 2020
Q4 2019	9.98	+2.7	+37.1%	Oct 1, 2019	Dec 31, 2019
Q3 2019	11.6	+4.17	+56.3%	Jul 1, 2019	Sep 30, 2019
Q2 2019	11.3	+4.12	+57.6%	Apr 1, 2019	Jun 30, 2019
Q1 2019	11.6	+3.9	+50.9%	Jan 1, 2019	Mar 31, 2019
Q4 2018	7.28	-5.57	-43.4%	Oct 1, 2018	Dec 31, 2018
Q3 2018	7.41	-5.99	-44.7%	Jul 1, 2018	Sep 30, 2018
Q2 2018	7.15	-7.73	-52%	Apr 1, 2018	Jun 30, 2018
Q1 2018	7.67	-6.63	-46.4%	Jan 1, 2018	Mar 31, 2018
Q4 2017	12.8	-2.71	-17.4%	Oct 1, 2017	Dec 31, 2017
Q3 2017	13.4	-3.81	-22.1%	Jul 1, 2017	Sep 30, 2017
Q2 2017	14.9	-2.37	-13.7%	Apr 1, 2017	Jun 30, 2017
Q1 2017	14.3	-2.85	-16.6%	Jan 1, 2017	Mar 31, 2017
Q4 2016	15.6	-0.16	-1.02%	Oct 1, 2016	Dec 31, 2016
Q3 2016	17.2	+2.53	+17.2%	Jul 1, 2016	Sep 30, 2016
Q2 2016	17.2	+3.18	+22.6%	Apr 1, 2016	Jun 30, 2016
Q1 2016	17.1	+1.65	+10.6%	Jan 1, 2016	Mar 31, 2016
Q4 2015	15.7	-7.27	-31.6%	Oct 1, 2015	Dec 31, 2015
Q3 2015	14.7	-9.13	-38.4%	Jul 1, 2015	Sep 30, 2015
Q2 2015	14.1	-10.6	-43%	Apr 1, 2015	Jun 30, 2015
Q1 2015	15.5	-8.61	-35.7%	Jan 1, 2015	Mar 31, 2015
Q4 2014	23	+6.4	+38.6%	Oct 1, 2014	Dec 31, 2014
Q3 2014	23.8	+8.14	+52%	Jul 1, 2014	Sep 30, 2014
Q2 2014	24.7	+11.1	+81.9%	Apr 1, 2014	Jun 30, 2014
Q1 2014	24.1	+12	+98.8%	Jan 1, 2014	Mar 31, 2014
Q4 2013	16.6	+5.16	+45.1%	Oct 1, 2013	Dec 31, 2013
Q3 2013	15.7	+5.42	+52.9%	Jul 1, 2013	Sep 30, 2013
Q2 2013	13.6	+1.65	+13.9%	Apr 1, 2013	Jun 30, 2013
Q1 2013	12.1	+1.46	+13.7%	Jan 1, 2013	Mar 31, 2013
Q4 2012	11.4			Oct 1, 2012	Dec 31, 2012
Q3 2012	10.3			Jul 1, 2012	Sep 30, 2012
Q2 2012	11.9			Apr 1, 2012	Jun 30, 2012
Q1 2012	10.7			Jan 1, 2012	Mar 31, 2012

* An asterisk sign (*) next to the value indicates that the value is likely invalid.